Ownership

Mark Bodenrader

Insider Reports History

Entity: Individual
Location: C/O Cerevel Therapeutics Holdings Inc., 131 Dartmouth Street Suite 502, Boston, MA
Signature: /s/ Mark Bodenrader
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Bodenrader:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Cerevel Therapeutics Holdings, Inc.	Senior Vice President, Finance and Chief Accounting Officer	Common Stock	0	$0	$41.18	Aug 1, 2024	Direct
Cerevel Therapeutics Holdings, Inc.	Senior Vice President, Finance and Chief Accounting Officer	Restricted Stock Units	0	$0	$41.18	Aug 1, 2024	Direct
Cerevel Therapeutics Holdings, Inc.	Senior Vice President, Finance and Chief Accounting Officer	Stock Option (Right to Buy)	0			Aug 1, 2024	Direct

Showing 1 to 3 of 3 entries

Insider Reports Filed by Mark Bodenrader

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
CERE	Cerevel Therapeutics Holdings, Inc.	Aug 1, 2024	3	$0	4	Aug 5, 2024	Senior Vice President, Finance and Chief Accounting Officer
CERE	Cerevel Therapeutics Holdings, Inc.	Jan 19, 2024	1	$0	4	Jan 23, 2024	Title: Senior Vice President, Finance and Chief Accounting Officer
CERE	Cerevel Therapeutics Holdings, Inc.	Dec 19, 2023	5	-$327K	4	Dec 21, 2023	Title: Senior Vice President, Finance and Chief Accounting Officer
CERE	Cerevel Therapeutics Holdings, Inc.	Jun 1, 2023	3	-$62.4K	4	Jun 5, 2023	Title: Senior Vice President, Finance and Chief Accounting Officer
CERE	Cerevel Therapeutics Holdings, Inc.	Feb 6, 2023	2	$0	4	Feb 8, 2023	Officer
CERE	Cerevel Therapeutics Holdings, Inc.	Jun 1, 2022	1	$0	4	Jun 3, 2022	Title: Interim Chief Financial Officer, Vice President, Finance and Chief Accounting Officer
CERE	Cerevel Therapeutics Holdings, Inc.	Feb 9, 2022	1	$0	4	Feb 11, 2022	Title: Interim Chief Financial Officer, Vice President, Finance and Chief Accounting Officer